DocWire News Editors

DocwireNews

Time changes things, and this study looked at the changes in medical therapy over time for patients who underwent first <a href="https://www.docwirenews.com/pad-knowledge-hub/temporal-changes-medication-pad-revascularization-patients/">revascularization for symptomatic peripheral artery disease</a> (PAD). The analysis, published in Circulation, included data on more than 32,000 participants who underwent revascularization for symptomatic PAD from 2000 to 2016. According to the analysis results, the cumulative use of medication increased between 2000 and 2004, and from 2013 to 2016, respectively. &ldquo;Despite increases in age and comorbidity, medical prevention of adverse events improved substantially over time, particularly in the first part of the study period and among patients who used medications chronically; in contrast, initiating treatment after revascularization increased modestly among treatment-na&iuml;ve patients,&rdquo; the authors wrote in the <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047994">study</a>.A study in the Journal of the American Heart Association reveals relationships between county-level <a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/county-level-factors-affect-race-ethnicity-specific-cvd-death/">factors associated with cardiovascular disease, and race/ethnicity.</a> The authors identified almost 660,000 cardiovascular disease-related deaths among non-Hispanic White individuals, 49,493 deaths among Hispanic/Latino individuals, and 100,475 deaths among non-Hispanic black <a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/young-black-adults-have-a-significantly-higher-risk-of-dying-following-heart-transplant/">individuals</a>. The highest mean-adjusted age-adjusted mortality rate occurred in non-Hispanic blacks, and the highest rates were seen in the Southern U.S. &ldquo;This study&rsquo;s greatest value is that it informs the understanding of cardiovascular population health and the numerous factors that play a role in cardiovascular health,&rdquo; a coauthor said in a press statement.Polynesian ancestry, according to a new study in PLoS Genetics, may be associated with an increased risk for obesity, as well as type 2 diabetes and heart disease. <a href="https://www.docwirenews.com/cardiology/polynesian-ancestry-may-increase-cardiometabolic-risk/">Unique genetic variants</a> linked to obesity, diabetes, and heart disease biomarkers were associated with increased odds of developing the conditions in a population of about 4,000 native Hawaiians from the Multiethnic Cohort Study. &ldquo;Our results suggest future studies could identify population-specific genetic susceptibility factors that may elucidate underlying biological mechanisms and [reduce] the disparity in disease risks in Polynesian populations,&rdquo; the authors wrote.Testosterone therapy was not linked with improved vascular function, according to a new study published in Hypertension. The skinny: Increased flow-mediated dilation percentage was seen with exercise training in the study, while <a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/testosterone-therapy-does-not-improve-vascular-function/">testosterone had no impact on flow-mediated dilation</a>, nor was it additive to exercise. &ldquo;While we conclude that exercise improves vascular function in middle-to-older aged men with low-normal testosterone levels, caution should be applied when prescribing testosterone if the primary aim is improvement in artery function and health,&rdquo; the authors wrote.

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Cardio Round-up: County-level Factors for CVD Linked with Race and Ethnicity; and More

Cardiology

Time changes things, and this study looked at the changes in medical therapy over time for patients who underwent first revascularization for symptomatic peripheral artery ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe